Literature DB >> 17333448

Modulation of soy isoflavones bioavailability and subsequent effects on bone health in ovariectomized rats: the case for equol.

J Mathey1, J Mardon, N Fokialakis, C Puel, S Kati-Coulibaly, S Mitakou, C Bennetau-Pelissero, V Lamothe, M J Davicco, P Lebecque, M N Horcajada, V Coxam.   

Abstract

INTRODUCTION: Soy products are of particular interest because of their potential health benefits in a range of hormonal conditions, such as osteoporosis, due to their high content in phytoestrogens. Because equol, the main metabolite from soy isoflavones, is thought to be powerful, the present study was designated to evaluate the bone-sparing effects of equol by either providing the molecule through the diet or by eliciting its endogenous production by modulating intestinal microflora by short-chain fructooligosaccharides (sc-FOS) or live microbial (Lactobacillus casei) together with daidzein, its precursor.
METHODS: A comparison with daidzein and genistein was also performed. Rats (3 months old) were ovariectomised (OVX) or sham-operated (SH). Ovariectomised rats were randomly assigned to six experimental diets for 3 months: a control diet (OVX), the control diet supplemented with either genistein (G), or daidzein (D), or equol (E) at the level of 10 microg/g body weight/d. The remaining OVX rats were given daidzein at the dose of 10 mug/g body weight/d, simultaneously with short-chain FOS (Actilight, Beghin-Meiji) (D+FOS) or Lactobacillus casei (Actimel, Danone) (D+L). The SH rats were given the same control diet as OVX.
RESULTS: Genistein, daidzein or equol exhibited a bone sparing effect. Indeed, total femoral bone mineral density (BMD) was significantly enhanced (compared to that of OVX rats), as was the metaphyseal compartment. Bone strength was improved by E consumption, but not by genistein or daidzein given alone. As far as the FOS diet is concerned, the addition of prebiotics significantly raised efficiency of the daidzein protective effect on both femoral BMD and mechanical properties. The effects of lactobacillus were similar, except that the increase in metaphyseal-BMD was not significant.
CONCLUSION: In conclusion, long-term equol consumption, like genistein and daidzein, in the ovariectomized rat, provides bone sparing effects. Adding indigestible sugars, such as FOS or live microbial as L. casei, in the diet significantly improves daidzein protective effects on the skeleton.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17333448     DOI: 10.1007/s00198-007-0351-y

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  51 in total

Review 1.  Effects of prebiotics on mineral metabolism.

Authors:  K E Scholz-Ahrens; G Schaafsma; E G van den Heuvel; J Schrezenmeir
Journal:  Am J Clin Nutr       Date:  2001-02       Impact factor: 7.045

2.  Animal models impacted by phytoestrogens in commercial chow: implications for pathways influenced by hormones.

Authors:  N M Brown; K D Setchell
Journal:  Lab Invest       Date:  2001-05       Impact factor: 5.662

Review 3.  Factors influencing the assay of creatinine.

Authors:  J G Cook
Journal:  Ann Clin Biochem       Date:  1975-11       Impact factor: 2.057

4.  Sex differences in bone growth of broiler chickens.

Authors:  N Rose; P Constantin; C Leterrier
Journal:  Growth Dev Aging       Date:  1996

5.  Digestion, excretion, and energy value of fructooligosaccharides in healthy humans.

Authors:  C Molis; B Flourié; F Ouarne; M F Gailing; S Lartigue; A Guibert; F Bornet; J P Galmiche
Journal:  Am J Clin Nutr       Date:  1996-09       Impact factor: 7.045

6.  Fructooligosaccharide consumption enhances femoral bone volume and mineral concentrations in rats.

Authors:  S Takahara; T Morohashi; T Sano; A Ohta; S Yamada; R Sasa
Journal:  J Nutr       Date:  2000-07       Impact factor: 4.798

7.  Daidzein conjugates are more bioavailable than genistein conjugates in rats.

Authors:  R A King
Journal:  Am J Clin Nutr       Date:  1998-12       Impact factor: 7.045

8.  Variations in metabolism of the soy isoflavonoid daidzein by human intestinal microfloras from different individuals.

Authors:  Fatemeh Rafii; Christy Davis; Miseon Park; Thomas M Heinze; Richard D Beger
Journal:  Arch Microbiol       Date:  2003-05-29       Impact factor: 2.552

9.  Specific evaluation of localized bone mass and bone loss in the rat using dual-energy X-ray absorptiometry subregional analysis.

Authors:  P Pastoureau; A Chomel; J Bonnet
Journal:  Osteoporos Int       Date:  1995-05       Impact factor: 4.507

Review 10.  Biochemical markers for assessing skeletal growth.

Authors:  S P Robins
Journal:  Eur J Clin Nutr       Date:  1994-02       Impact factor: 4.016

View more
  12 in total

1.  Soy protein diet and exercise training increase relative bone volume and enhance bone microarchitecture in a mouse model of uremia.

Authors:  Emily J Tomayko; Hae R Chung; Kenneth R Wilund
Journal:  J Bone Miner Metab       Date:  2011-06-03       Impact factor: 2.626

2.  Equol, via dietary sources or intestinal production, may ameliorate estrogen deficiency-induced bone loss.

Authors:  Connie M Weaver; Leecole L Legette
Journal:  J Nutr       Date:  2010-05-26       Impact factor: 4.798

Review 3.  The pros and cons of phytoestrogens.

Authors:  Heather B Patisaul; Wendy Jefferson
Journal:  Front Neuroendocrinol       Date:  2010-03-27       Impact factor: 8.606

4.  Positive skeletal effects of cladrin, a naturally occurring dimethoxydaidzein, in osteopenic rats that were maintained after treatment discontinuation.

Authors:  K Khan; K Sharan; G Swarnkar; B Chakravarti; M Mittal; T K Barbhuyan; S P China; M P Khan; G K Nagar; D Yadav; P Dixit; R Maurya; N Chattopadhyay
Journal:  Osteoporos Int       Date:  2012-08-30       Impact factor: 4.507

Review 5.  Equol: pharmacokinetics and biological actions.

Authors:  Kenneth D R Setchell; Carlo Clerici
Journal:  J Nutr       Date:  2010-06-02       Impact factor: 4.798

6.  Supplemental dietary racemic equol has modest benefits to bone but has mild uterotropic activity in ovariectomized rats.

Authors:  Leecole L Legette; Berdine R Martin; Mohammad Shahnazari; Wang-Hee Lee; William G Helferich; Junqi Qian; David J Waters; Alireza Arabshahi; Stephen Barnes; Jo Welch; David G Bostwick; Connie M Weaver
Journal:  J Nutr       Date:  2009-08-26       Impact factor: 4.798

Review 7.  Soy Isoflavones and Osteoporotic Bone Loss: A Review with an Emphasis on Modulation of Bone Remodeling.

Authors:  Xi Zheng; Sun-Kyeong Lee; Ock K Chun
Journal:  J Med Food       Date:  2015-12-15       Impact factor: 2.786

8.  Effects of Extracts from Trifolium medium L. and Trifolium pratense L. on Development of Estrogen Deficiency-Induced Osteoporosis in Rats.

Authors:  Urszula Cegieła; Joanna Folwarczna; Maria Pytlik; Grażyna Zgórka
Journal:  Evid Based Complement Alternat Med       Date:  2012-11-29       Impact factor: 2.629

9.  Hwangryun-Haedok-Tang Fermented with Lactobacillus casei Suppresses Ovariectomy-Induced Bone Loss.

Authors:  Ki-Shuk Shim; Taesoo Kim; Hyunil Ha; Chang-Won Cho; Han Sung Kim; Dong-Hyun Seo; Jin Yeul Ma
Journal:  Evid Based Complement Alternat Med       Date:  2012-10-02       Impact factor: 2.629

Review 10.  Vitamin D interactions with soy isoflavones on bone after menopause: a review.

Authors:  Clara Y Park; Connie M Weaver
Journal:  Nutrients       Date:  2012-11-06       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.